No abstract available
MeSH terms
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / economics
-
Antipsychotic Agents / therapeutic use*
-
Chronic Disease
-
Cost-Benefit Analysis
-
Drug Costs
-
Drug Substitution
-
Humans
-
Marketing / economics
-
Medication Adherence
-
Patient Dropouts
-
Perphenazine / adverse effects
-
Perphenazine / economics
-
Perphenazine / therapeutic use
-
Randomized Controlled Trials as Topic
-
Schizophrenia / diagnosis
-
Schizophrenia / drug therapy*
-
Schizophrenia / economics
-
Schizophrenic Psychology*
-
United States
Substances
-
Antipsychotic Agents
-
Perphenazine